Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. The kinase inhibitor nintedanib specific for vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor receptor (FGFR) significan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Hostettler, Katrin E, Zhong, Jun, Papakonstantinou, Eleni, Karakiulakis, George, Tamm, Michael, Seidel, Petra, Sun, Qingzhu, Mandal, Jyotshna, Lardinois, Didier, Lambers, Christopher, Roth, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273482/
https://ncbi.nlm.nih.gov/pubmed/25496490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-014-0157-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados